Cargando…
Interplay of Epidermal Growth Factor Receptor and Signal Transducer and Activator of Transcription 3 in Prostate Cancer: Beyond Androgen Receptor Transactivation
SIMPLE SUMMARY: Androgen receptor (AR) signaling mainly controls prostate cancer (PCa) growth. Hence, the conventional regimen for PCa includes androgen deprivation therapy (ADT) or antiandrogen in order to reduce PCa recurrence. However, castration-resistant prostate cancer (CRPC) is insensitive to...
Autores principales: | Lin, Shian-Ren, Yeh, Hsiu-Lien, Liu, Yen-Nien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307975/ https://www.ncbi.nlm.nih.gov/pubmed/34298665 http://dx.doi.org/10.3390/cancers13143452 |
Ejemplares similares
-
Nrf1 and Nrf2 Transcription Factors Regulate Androgen Receptor Transactivation in Prostate Cancer Cells
por: Schultz, Michelle A., et al.
Publicado: (2014) -
Androgen receptor regulates SRC expression through microRNA-203
por: Siu, Man Kit, et al.
Publicado: (2016) -
The Chicken Ovalbumin Upstream Promoter-Transcription Factor II Negatively Regulates the Transactivation of Androgen Receptor in Prostate Cancer Cells
por: Song, Chin-Hee, et al.
Publicado: (2012) -
Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer
por: Tsai, Yuan-Chin, et al.
Publicado: (2018) -
Androgen Receptor-Mediated Transcription in Prostate Cancer
por: Özturan, Doğancan, et al.
Publicado: (2022)